Pharminent

AbbVie takes anti-tau drug into phase II for Alzheimer’s

Also testing
antibody in rare condition PSP, for which FDA has awarded
fast-track designation http://www.pmlive.com/pharma_news/abbvie_takes_anti-tau_drug_into_phase_ii_for_alzheimers_1185122

Filed under: Alzheimer’s